These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23107218)

  • 41. An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.
    Codecasa L; Mantegani P; Galli L; Lazzarin A; Scarpellini P; Fortis C
    J Clin Microbiol; 2006 Jun; 44(6):1944-50. PubMed ID: 16757583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of an in vitro assay for gamma interferon production in response to Mycobacterium tuberculosis infections.
    Taggart EW; Hill HR; Ruegner RG; Martins TB; Litwin CM
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1089-93. PubMed ID: 15539511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Tuberculosis and HIV infection--main diagnostic and therapeutic problems].
    Dabrowska MM; Pogorzelska J; Parfieniuk A; Siwak E; Wiercińska-Drapało A
    Pol Merkur Lekarski; 2007 Sep; 23(135):212-4. PubMed ID: 18080698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is the T-cell-based interferon-gamma releasing assay feasible for diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country?
    Dilektasli AG; Erdem E; Durukan E; Eyüboğlu FÖ
    Jpn J Infect Dis; 2010 Nov; 63(6):433-6. PubMed ID: 21099095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dual skin tests with Mycobacterium avium sensitin and PPD to detect misdiagnosis of latent tuberculosis infection.
    Larson EM; O'Donnell M; Chamblee S; Horsburgh CR; Marsh BJ; Moreland JD; Johnson LS; von Reyn CF
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1504-9, i. PubMed ID: 22008764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.
    Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A
    Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Update on latent tuberculosis infection.
    Hartman-Adams H; Clark K; Juckett G
    Am Fam Physician; 2014 Jun; 89(11):889-96. PubMed ID: 25077395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors.
    Papay P; Primas C; Eser A; Novacek G; Winkler S; Frantal S; Angelberger S; Mikulits A; Dejaco C; Kazemi-Shirazi L; Vogelsang H; Reinisch W
    Aliment Pharmacol Ther; 2012 Nov; 36(9):858-65. PubMed ID: 22978645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis of latent tuberculosis infection (LTBI) before anti-TNF-alpha treatment--the tuberculin skin test is useful.
    Goujon C; Nosbaum A; Bensaid B; Rozières A; Nicolas JF; Bérard F
    Eur J Dermatol; 2012; 22(5):701-2. PubMed ID: 23032063
    [No Abstract]   [Full Text] [Related]  

  • 50. [Latent tuberculosis infection: diagnosis and treatment].
    Bendayan D; Raz M; Kramer MR
    Harefuah; 2002 Mar; 141(3):233-6, 316. PubMed ID: 11944212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Challenges in diagnosis and treatment of latent tuberculosis infection.
    Gupta KB
    Indian J Tuberc; 2012 Jan; 59(1):1-5. PubMed ID: 22670504
    [No Abstract]   [Full Text] [Related]  

  • 52. High Prevalence of Active and Latent Tuberculosis in Children and Adolescents in Tibetan Schools in India: The Zero TB Kids Initiative in Tibetan Refugee Children.
    Dorjee K; Topgyal S; Dorjee C; Tsundue T; Namdol T; Tsewang T; Nangsel T; Lhadon D; Choetso T; Dawa T; Phentok T; DeLuca AN; Tsering L; Phunkyi D; Sadutshang TD; J Bonomo E; Paster Z; Chaisson RE
    Clin Infect Dis; 2019 Aug; 69(5):760-768. PubMed ID: 30462191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Update in tuberculosis and nontuberculous mycobacterial disease 2012.
    Menzies D; Nahid P
    Am J Respir Crit Care Med; 2013 Oct; 188(8):923-7. PubMed ID: 24127799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug therapy for children with tuberculosis.
    Ormerod LP
    Arch Dis Child; 2012 Dec; 97(12):1097-101. PubMed ID: 23104773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Time interval to conversion of interferon-gamma release assay after exposure to tuberculosis.
    Lee SW; Oh DK; Lee SH; Kang HY; Lee CT; Yim JJ
    Eur Respir J; 2011 Jun; 37(6):1447-52. PubMed ID: 21148232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis.
    Nemeth J; Winkler HM; Karlhofer F; Selenko-Gebauer N; Graninger W; Winkler S
    Eur Cytokine Netw; 2010 Mar; 21(1):34-9. PubMed ID: 20146988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recurrence of active tuberculosis following resumption of anti-TNF-α therapy in a patient with Crohn's disease.
    Masiá M; Martínez M; García-Sepulcre MF; Sáez J; Gutiérrez F
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):249-50. PubMed ID: 24429322
    [No Abstract]   [Full Text] [Related]  

  • 58. Screening for Latent Tuberculosis Infection: A Key Step Toward Achieving Tuberculosis Elimination in the United States.
    Reves R; Daley CL
    JAMA Intern Med; 2016 Oct; 176(10):1439-1440. PubMed ID: 27599130
    [No Abstract]   [Full Text] [Related]  

  • 59. Latent infection treatment to prevent TB transmission in school settings.
    Lee PH; Chang FY
    J Formos Med Assoc; 2012 Oct; 111(10):525-6. PubMed ID: 23089686
    [No Abstract]   [Full Text] [Related]  

  • 60. Diagnosis and Management of Latent Tuberculosis Infection.
    Muñoz L; Stagg HR; Abubakar I
    Cold Spring Harb Perspect Med; 2015 Jun; 5(11):. PubMed ID: 26054858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.